224 EFFECT OF LENGTHENING THE SUPERSTIMULATORY TREATMENT PROTOCOL ON THE OVARIAN RESPONSE AND NUMBERS OF TRANSFERABLE EMBRYOS IN BEEF COWS

2012 ◽  
Vol 24 (1) ◽  
pp. 224
Author(s):  
A. Garcia Guerra ◽  
A. Tribulo ◽  
J. Yapura ◽  
J. Singh ◽  
R. J. Mapletoft

The present study was designed to test the hypothesis that an increase in the length of exposure of ovulatory follicles to progesterone and FSH during ovarian superstimulation will increase the number of ovulations and viable embryos in cattle. Twenty-four beef cows were initially subjected to follicle ablation at random stages of the oestrous cycle to determine the number of follicles at wave emergence; cows with comparable numbers of follicles were randomly allocated to groups by replicate. A single dose of prostaglandin F2α (PGF; Estroplan, Vétoquinol, QC, Canada) was given IM 7 to 9 days after follicle ablation and daily ultrasound examinations were performed to detect ovulation. Follicular ablation of all follicles ≥5 mm was done 5 to 8 days after ovulation and a progesterone-releasing intravaginal device (PRID, Vétoquinol) was inserted. The Control group (n = 12) was treated with 4 days of FSH and cows in the Long group (n = 12) were given 7 days of FSH treatment. The FSH treatments were initiated 1.5 days after ablation (Day 0) with a total dose of 400 mg of NIH-FSH-P1 (Folltropin-V; Bioniche Animal Health, Belleville ON, Canada). The total dose of FSH was distributed equally over 8 (Control) or 14 (Long) IM injections at 12-h intervals. Prostaglandin F2α was administered twice (at 12-h intervals) on Day 2 (Control) or Day 5 (Long) and PRID were removed 12 h after the last PGF. Both groups received 25 mg of porcine LH (pLH) IM (Lutropin-V; Bioniche Animal Health) 24 h after PRID removal and AI with frozen–thawed semen of proven fertility was done 12 and 24 h later. A third AI was done 12 h later in cows with 2 or more follicles ≥9 mm (12/12 and 9/12 in Control and Long groups, respectively; P = 0.22). All animals were subjected to transrectal ultrasonography every other day and at the time of ova or embryo collection. Ova or embryos were collected nonsurgically 7 days after the pLH injection and evaluated following IETS guidelines. Embryos were defined as transferable (Grades 1, 2 and 3) and freezable (Grades 1 and 2). Procedure Genmod was used to compare variables between treatments and results are presented as means ± SEM (Table 1). There was no significant difference in the total numbers of ova/embryos recovered, but there were more ovulations, corpora lutea (CL), fertilized ova and transferable and freezable embryos in the Long group (P < 0.05). Collection efficiency (number of ova/embryos over the number of CL) was lower in the Long group (P < 0.05). In summary, lengthening of the superstimulatory treatment resulted in an increased number of ovulations without a decrease in oocyte or embryo competence. Data suggest that the traditional 4-day superstimulatory treatment protocol provides inadequate time to maximize ovulatory response. Table 1.Superovulatory response (mean ± SEM) of cows subjected to a conventional 4-day (Control) or a 7-day (Long) treatment protocol

2012 ◽  
Vol 24 (1) ◽  
pp. 224 ◽  
Author(s):  
R. L. Davis ◽  
A. Arteaga ◽  
J. F. Hasler

This study examined the superovulatory responses of Bos taurus beef cows maintained in a commercial embryo transfer facility. Donors were superovulated 1 to 3 times each with either a traditional 8 injection FSH protocol (controls, n = 126) or 6 injections of FSH with the seventh or eighth FSH treatments replaced by 2 injections of eCG (treatment, n = 134). During the 5-month study, 132 donors were alternatively assigned to a control or treatment group for a single superovulation and an additional 62 animals were superovulated 2 (n = 58) or 3 times (n = 4) in a crossover design. Although 14 beef breeds were represented in the study, 87% of the cows were Angus, Red Angus, Polled Hereford, or Charolais. All donors were synchronized on Day 0 with a CIDR, 5 mg of oestradiol-17β and 100 mg of progesterone. Starting on Day 4 (p.m.), controls were injected twice daily for 4 days with descending doses of porcine FSH (Folltropin-V®, Bioniche Animal Health, Belleville, Ontario, Canada). Cows received 750 μg of cloprostenol (Estrumate®, Intervet Schering-Plough, Summit, NJ, USA) at the seventh FSH injection and the CIDR was removed at the eighth FSH injection. Based on previous experience with specific, individual animals, total FSH dose per donor ranged from 240 to 400 mg. However, 74% of treatments involved 380 mg for controls and 310 mg for treated donors that received eCG. In addition, donors that were superovulated more than once received the same FSH dose in the crossover, treatment-control design. In the treatment group, 200 IU of eCG (Pregnecol™ 6000, Bioniche Animal Health) was substituted for the seventh and eighth FSH injections. Inseminations were conducted on a timed AI basis, with one unit of semen 32 h and a second 48 h following CIDR removal. Results were analysed by ANOVA as shown in Table 1. Although more ova/embryos and unfertilized ova (UFO) were recovered in the control group, the control and treatment groups did not differ in the number of grade 1, 2, or 3 embryos or in the number of degenerate embryos. Previous superovulation studies in South America using eCG to replace the last 2 injections of FSH resulted in more total ova/embryos in Nelore cows but not heifers and in more embryos in Brangus and Sindhi cows. The mean embryo production for the control cows in this study was high and the addition of eCG in the protocol did not improve embryo production. Failure of eCG to increase the number of embryos for Bos taurus cows in this study compared with previous studies may be due to differences with Bos taurus versus Bos indicus breeds or differences in management factors between Canada and South America. The high response rate in the controls may also have contributed to the failure of any advantage of adding eCG to the treatment protocol. Table 1.Mean numbers (± SEM) of ova and embryos recovered from Bos taurus females superovulated with 2 different protocols


2015 ◽  
Vol 27 (1) ◽  
pp. 143
Author(s):  
C. M. B. Membrive ◽  
M. B. Cordeiro ◽  
D. Pazzanese ◽  
G. Pugliesi ◽  
M. F. Sá Filho ◽  
...  

Embryo death between 15 and 19 days of pregnancy is caused by the increase in the release of endometrial prostaglandin F2α (PGF2α) involved in the luteolysis process in cattle. Compounds rich in linoleic acid, such as sunflower seeds, provide lipid changes in the endometrium, and may be involved in the ability of PGF2α biosynthesis. Previous studies observed that the conception rate increased in Nelore cows supplemented with sunflower seed for 22 days from the timed AI (66.7% v. 46.3%; Peres et al. 2008, Acta Sci. Vet. 36, 639) and in crossbred heifers submitted to timed embryo transfer (55.66% v. 36.94%; Membrive et al. 2013 Acta Sci. Vet. 36, 603). We aimed to test the hypothesis that supplementation with sunflower seed promotes endometrial changes in lipid composition. Thus, we compared the composition of fatty acids in endometrial tissue in cows supplemented or not with sunflower seed. Nelore (n = 30) cows received an intravaginal device containing progesterone (1 g; DIB, Syntex Biochemistry & Pharmaceutical Industries SA, Buenos Aires, Argentina) associated with an im injection of oestradiol benzoate (2 mg; Benzoate HC, Hertape Calier Animal Health SA, Juatuba, MG, Brazil). The devices were removed after 8 days, when cows were treated im with cloprostenol sodium (2 mg; Sincrocio®, Ourofino Animal Health Ltd., Cravinhos, SP, Brazil), oestradiol cypionate (0.5 mg; ECP®, Zoetis Ltda., São Paulo, Brazil) and eCG (300 IU; Folligon®, Intervet Veterinary Ltda., Cotia, Brazil). Two days after removal of the device, females were assigned into 6 groups to receive 1.7 kg/animal/day of 40% soybean meal, 44% crude protein (CP) + 60% sunflower seed for 6 (n = 4), 14 (n = 5) and 22 days (n = 6), or 53% soybean meal, 44% CP + 47% corn for 6 (n = 4), 14 (n = 5) and 22 days (n = 6). Both diets were formulated with 72% total digestible nutrients and 24% CP. Females were slaughtered 24 h after the end of supplementation and endometrial tissue was isolated and stored at –196°C. The fatty acids in endometrial tissue were assessed by gas chromatography. Data were analysed by SAS Proc GLIMMIX (SAS Institute Inc., Cary, NC, USA). The fatty acid profile (54 compounds) was analysed and 43 fatty acids were present in the endometrial tissue. The lacking fatty acids in endometrial tissue were C4:0, C11:0, C12:1, C: 13:0, C13:0 iso, C13:0 anteiso, C14:0 iso, C15:1, C18:1 trans-16, C18:2 cis-12, trans-10, and C21:0. The fatty acids that showed a higher percentage compared with the Control group were C18:1 trans-10-trans-11-trans-12 and C10:1. The fatty acids that showed low percentage compared with the Control group were C15:0 iso, C20:5, C20:3n-3, C23:0, C24:0, and C22:5. In conclusion, supplementation with sunflower seed promotes changes in the endometrial lipid profile that may reduce the pregnancy loss in beef cows. Research supported by FAPESP, FUNDUNESP, and Santa Encarnação Farm.


2020 ◽  
Vol 32 (2) ◽  
pp. 202
Author(s):  
Y. Aoyagi ◽  
M. Takeuchi ◽  
T. Oono ◽  
K. Hayama ◽  
M. Urakawa ◽  
...  

The objective of this study was to evaluate the effect of inducing oestrus in superovulation-treated Japanese Black donor cows after egg collection using a controlled internal drug release (CIDR) device and prostaglandin F2α treatments. The test animals were 50 biparous or triparous Japanese Black cows that had been treated for superovulation during the period of 75-110 days post-calving and from each of which 10 or more ova or embryos had been recovered using a uterine reflux method. In the 25 cows of the control group that received the conventional treatment, a CIDR was not introduced into the vagina, the number of days from egg harvesting to standing oestrus was recorded, and AI was performed using frozen semen. At the time of AI, 50µg of gonadotrophin-releasing hormone (GnRH; Consultan, Aska Animal Health) was administered intramuscularly. The cows that did not conceive in the first AI attempt were again given the same AI and GnRH treatments in the next oestrus cycle. In the 25 cows of the treatment group, a CIDR (CIDR 1900, Zoetis) device was inserted in the vagina after egg harvesting and was kept there for 12 days. At the time of insertion and removal of the CIDR, 150µg of d-cloprostenol formulation (Dalmazin, Kyoritsu Seiyaku) was administered intramuscularly. The number of days from egg harvest to standing oestrus was recorded, and GnRH was administered at the time of AI. The cows that did not conceive in the first AI attempt were given the same AI and GnRH treatments in the next oestrus cycle. The control and treatment groups were compared for the number of days from egg harvesting to oestrus (t-test) and the conception rate after AI (chi-square test). The mean number of days from egg collection to standing oestrus in the control group was 38.6±11.9, and the conception rate was 60% (15/25). Among the animals that failed to conceive in the first AI attempt, the second standing oestrus occurred 60.7±13.1 days after egg collection, and 70% (7/10) of the cows conceived after the second AI. In the treatment group, on the other hand, the mean number of days from egg collection to standing oestrus was 15.8±3.9, and 72% (18/25) of the cows conceived after the first AI. Among the cows that failed to conceive, the second standing oestrus occurred 37.4±4.7 days after egg harvest, and 71% (5/7) of the cow conceived after the second AI. There was a significant difference between the two groups in the number of days from egg collection to the first standing oestrus (P&lt;0.05). The results described above suggest that keeping a CIDR in the vagina for 12 days and intramuscularly administering prostaglandin F2α at the time of insertion and removal of the CIDR in superovulated cows are effective for early onset of standing oestrus after egg collection and thus can reduce the number of days to conception.


2021 ◽  
Vol In Press (In Press) ◽  
Author(s):  
Ahmad Najafi ◽  
Alireza Sharif ◽  
Mohammadreza Sharif ◽  
Hamidreza Gilassi

Background: Pneumonia, as a fairly prevalent illness, is the main cause of hospital mortality. The major cause of mortality and morbidity of pneumonia is due to bacteria. The presence of multi-drug resistant pathogens and no response to treatment have aroused considerable interest in the use of probiotic components to prevent infections. Objectives: Given that few studies have evaluated the efficacy of probiotics in reducing bacterial pneumonia, the current aimed to evaluate the role of probiotics in decreasing pneumonia. Methods: This double-blind, randomized clinical trial study was conducted on 100 patients diagnosed with bacterial pneumonia in Shahid Beheshti Hospital, Kashan, Iran, during 2018. Patients were randomly classified into two groups (n = 50). One group (case) received two sachets of probiotic/daily for five days, and another group (control) received placebo. Moreover, patients in both groups received the same treatment protocol. All data were extracted from medical records. Chi-square test and independent t-test were used for analysis of data. P < 0.05 was considered statistically significant. Results: No significant difference was seen between case and control groups regarding age, gender, and duration of symptoms before hospitalization (P > 0.05), which implies a completely random classification of two groups. The mean duration of hospitalization, dyspnea, tachypnea, cough, fever, and crackles was significantly decreased in the case group compared to the control group (P < 0.05). Conclusion: The use of probiotics can be effective in reducing the duration of dyspnea, tachypnea, cough, fever, and length of hospitalization. Therefore, probiotics may be considered a promising treatment for the development of new anti-infectious therapy. In addition, the usage of probiotics along with antibiotics is suggested for decreasing pneumonia complications and improving the efficacy of therapy.


2018 ◽  
pp. 92-97
Author(s):  
G.V. Strelko ◽  
◽  
V.V. Ulanova ◽  

The objective: determination of the frequency of detection, risk factors, diagnostic criteria for chronic endometritis in poor responders patients in ART cycles with the study of the effectiveness of the proposed regimens for the treatment of this pathological condition. Materials and methods. A clinical study of the diagnosis of chronic endometritis in in poor responders patients have been conducted to develop individual approaches to overcoming infertility in a given cohort of women, taking into account not only the ovarian reserve, but also the endometrial status, assessed by clinical, instrumental and laboratory research methods, for achievement of successful implantation and ongoing pregnancy. The control group of women included 93 patients with infertility, a normal ovarian response to stimulation and lack of criteria for bad defendants. Results. As a result of a study conducted in poor responders patients, there is a significant percentage of the presence of chronic endometritis, which greatly complicates the overcoming of infertility. Risk factors for the occurrence of this pathological condition are genital tract infections, surgical intervention, intrauterine manipulations. Diagnostic criteria for chronic endometritis in women with infertility are micropolips, stomach edema, local and diffuse congestion of the endometrium during hysteroscopic examination and high expression of the imunohistochemical marker CD-138. Conclusion. The treatment protocol of the first line of chronic endometritis – docxicillin 100 mg 2 times a day 14 days, neomycin sulfate 35 000 MU, polymyxin B sulfate 35 000 MU, nystatin 100 000 MU for 1 suppositirium 1 time per day for 10 days and diclofenac 100 mg rectally for 5 days – is effective in 67.5% of cases . In patients who are resistant to previous antibiotic therapy, the second line treatment regimen is – сefotaxime 2.0 i /v 1 time per day, gentamycin 80 mg 3 times a day in / m, metronidazol 100 ml per day i / v, and diclofenac 100 mg rectally once daily for 7 days – the effectiveness of the treatment of chronic endometritis reached 79.1% of the cases. Key words: chronic endometritis, infertility, poor responders, ART.


Author(s):  
Sravani Manam ◽  
R. N. V. Swetha ◽  
A. S. Kameswara Rao ◽  
S. G. K. Murthy

Background: The ultrasound guided transversus abdominis plane (TAP) block which provides effective analgesia after lower abdominal surgeries including caesarean section. It is a simple and reliable technique. In this prospective, randomized double-blind study, we determined the efficacy of TAP block using 0.25% Bupivacaine and 0.9N Saline with respect to VAS for pain, postoperative Tramadol consumption and post-operative ondansetron usage.Methods: This study was conducted on 100 adult patients of ASA physical status I and II in the   age group of 18 to 40 years undergoing elective lower segment cesarean section under spinal anaesthesia. Study group received TAP block with 0.25% Bupivacaine and control group received 10 ml of 0.9N saline on each side. Patients were analyzed for postoperative pain by pain score (at rest, on movement, on cough) using VAS was recorded at 0, ½, 1, 2, 4, 6, 12 and 24 hours postoperatively. Need for rescue analgesia was assessed by time to first dose of Tramadol requirement and total dose of Tramadol over 24 hours of postoperative period. Ondansetron (4 mg i.v.) was administered whenever nausea score was more than 2 or the patient vomited. All the data was noted using uniform performs.Results: Patients received TAP block with 0.25% Bupivacaine had better pain scores at first hour of postoperative period during rest, cough and movement which was statistically significant (p<0.0010) in comparison to group B. There was a statistically significant difference (p <0.001) in the requirement of total dose of Tramadol as a rescue analgesia in patients who received transversus abdominis block with 0.25% Bupivacaine (138.77 mg) in comparison with other group(240 mg).The mean time to first request for Tramadol was significantly longer in group A (5.8 hrs)  in comparison to group B (1.93 hrs) with p value <0.001. Patients received TAP block with 0.9N saline needed more dose of Ondansetron, however, the difference was not statistically significant (p >0.001).Conclusions: TAP block using ultrasound provides substantial reduction in Tramadol consumption, time to first dose of rescue tramadol when compared with control group. This study reinforces the recommendation for TAP as a part of multimodal post-operative analgesic regimen.


2006 ◽  
Vol 18 (2) ◽  
pp. 115
Author(s):  
H. Davis ◽  
M. Colazo ◽  
M. Rutledge ◽  
J. Small ◽  
J. Kastelic ◽  
...  

Two experiments were conducted to determine the effects of plasma progesterone (P4) concentrations on LH release and ovulation in beef heifers and lactating beef cows given gonadotropin-releasing hormone (GnRH). Previously autoclaved, once-used CIDR inserts (Colazo et al. 2004 Anim. Reprod. Sci. 81, 25-34) were used for experimental purposes to induce differential plasma progesterone concentrations. In Experiment 1, postpubertal heifers received 25 mg of dinoprost i.m. (prostaglandin F (PGF); Lutalyse; Pfizer Animal Health, Montreal, Quebec, Canada). On Day 4 (estrus = Day 0), heifers were randomly assigned (10/group) to receive no treatment (control) or 1 or 2 autoclaved once-used CIDR (Pfizer Animal Health) inserts (1CIDR and 2CIDR, respectively). On Day 5, heifers in the 1CIDR group were given PGF twice 12 h apart. On Day 6, all heifers received 100 �g of GnRH i.m. (Cystorelin; Merial Canada, Inc., Victoriaville, Quebec, Canada). Once daily on Days 4 to 9, a blood sample was collected and ultrasonography was performed. On Day 6, heifers in the control (3.0 � 0.4 ng/mL; mean � SD) and 1CIDR groups (3.0 � 0.3 ng/mL) had lower (P < 0.01) plasma progesterone concentrations than those in the 2CIDR group (5.7 � 0.4 ng/mL). However, the diameter of the dominant follicle was larger (P < 0.001) in heifers in the control and 1CIDR groups than in the 2CIDR group (12.1 � 1.0, 11.5 � 0.7, and 10.1 � 0.7 mm, respectively). More (P < 0.01) heifers ovulated in response to GnRH in the control and 1CIDR groups than in the 2CIDR group (10/10, 9/10, and 3/10, respectively). In Experiment 2, ultrasound-guided follicular ablation (FA) was performed (to synchronize ovarian follicular wave emergence) 4 to 6 days after estrus in 20 postpubertal heifers and 20 mature lactating cows. Cattle were randomly and equally assigned to receive an autoclaved, once-used CIDR, either with no further treatment (High-P4) or with two PGF treatments 12 h apart (Low-P4) given after FA. All cattle received 100 �g of GnRH either 6 days after FA or the day after the dominant follicle reached 9 mm in diameter. Ultrasonography was performed daily (from 4 days after FA to ovulation or to 3 days after GnRH treatment). In three cows and three heifers per group, blood samples were collected every 30 min for 12 h after GnRH. The dominant follicle at GnRH treatment was larger in cows than heifers (11.0 � 1.1 vs. 10.3 � 0.9 mm, respectively; P = 0.05) and tended to be smaller in the High-P4 group vs. the Low-P4 group (10.3 � 1.0 vs. 11.0 � 1.0 mm; P = 0.06). Ovulatory response was not different (P = 0.9) between heifers (77.7%) and cows (78.9%), but combined for heifers and cows, was lower in High-P4 vs. Low-P4 cattle (61.1 vs. 94.7; P < 0.01). The GnRH-induced LH surge did not differ (P = 0.23) between cows and heifers, but it was lower and of shorter duration (P < 0.001) in the High-P4 group than in the Low-P4 group. In summary, higher plasma P4 concentrations resulted in decreased LH release and the proportion of cattle ovulating in response to GnRH treatment. There was no significant difference between heifers and cows in LH release or ovulatory response.


2008 ◽  
Vol 20 (1) ◽  
pp. 227
Author(s):  
A. Garcia Guerra ◽  
G. A. Bó ◽  
J. Villarreal ◽  
G. M. Brogliatti

Ovarian asynchrony and variability in response to superstimulation remain the most limiting factors in any embryo transfer program (Armstrong D 1993 Theriogenology 39, 7–24). Ovarian response can be increased and less variable if superstimulatory treatment is started at the time of follicular wave emergence (Bö GA et al. 1995 Theriogenology 43, 31–40). A combination of progesterone (P4) and estradiol have been used to synchronize follicular wave for superstimulation. A retrospective analysis was done to compare the ovarian response, superovulatory response and embryo production of cows in Argentina that received progesterone and estradol prior to superstimulation at different stages of the estrous cycle. This research was carried out using different breed of donors (n = 584, 88% Angus) during the last 4 years in Buenos Aires province, Argentina. Heat detection was performed twice a day. At random stages of the estrous cycle, donors received an intravaginal progesterone device (DIB; Syntex, Buenos Aires, Argentina), 2 mg of estradiol benzoate and 50 mg of progesterone (Syntex, Buenos Aires, Argentina) IM on the same day. On day 4 after DIB insertion, superestimulatory treatment was initiated on a decreasing dose regimen of FSH (Pluset; Callier, Spain, or Folltropin, Bioniche Animal Health Inc., Belleville, Ontario, Canada) as IM injections every 12 h over 4 d. On day 6, DIBs were removed, and cows received two doses of 2 mL of cloprostenol 12 h apart. At heat detection, all donors received a dose of 2 mL of GnRH (Dalmarelin; Fatro Von Franken, Buenos Aires, Argentina) by IM injection and were inseminated 12 and 24 h later. Seven days later, embryo collection was performed and ovarian response was evaluated as number of CL + unovulated follicles by transrectal ultrasound using a 7.5-MHz transducer (Pie Medical, Maastricht, the Netherlands). Ova/embryos were evaluated and classified according to the IETS manual. Donors were assigned to receive DIB and estradiol during the following stages of the cycle: group 1: between days 4 and 7 post-estrus (dominant follicle period), group 2: between days 8 and 12 post-estrus (emergence of the second follicular wave), and group 3: between days 13 and 21 post-estrus (dominant follicle of the second wave). Kruskal-Wallis test was used to compare variables among groups, and results are shown in Table 1. Ovarian response as CL + unovulated follicles and number of ovulations were significantly different among groups (P < 0.05). However, there was no significant difference in the number of fertilized ova or transferable embryos. Nevertheless, numeric differences that show that group 2 (started between days 8 and 12 post-estrus) was always superior for all variables. In conclusion, data suggest that estradiol may be more effective in synchronizing follicle wave emergence for superstimulation during the mid-part of the estrous cycle. Table 1. Superovulatory response in cows in which follicle wave emergence was synchronized with estradiol at different stages of the estrous cycle (mean ± SD) Research supported by Centro Genetico Bovino Eolia S.A.


2013 ◽  
Vol 25 (1) ◽  
pp. 307
Author(s):  
S. Kmaid ◽  
J. M. Saldaña

Current superovulatory treatment combines progesterone as well as oestradiol injection at the moment of CIDR insertion to improve synchronization of follicular wave emergence [reviewed by Bo et al. 2002 Theriogenology 57, 53–172; and Mapletoft et al. 2003 J. Anim. Sci. 81 (E. Suppl.), E28–E36] The aim of the present work was to study if delaying oestradiol benzoate (EB) injection 24 or 48 h from CIDR insertion would have the same outcome on embryo production after superovulatory treatment as additional progesterone administered at CIDR insertion. One hundred and eleven superovulatory treatments conducted during the same period (5 consecutive collection days) at random stages of the oestrus cycle at the same location were retrospectively evaluated. Holstein cycling heifers of 18 months of age (body condition score 3.2 ± 0.28, 1–5 range; weighing 357 ± 28 kg) were divided according to the following treatments: control group (n = 24): Day 0: CIDR insertion (Pfizer Animal Health, New York, NY, USA), 50 mg of progesterone, and 2 mg of oestradiol benzoate (Benzadiol, Universal Laboratory, Montevideo, Uruguay); Group BE24 (n = 47): Day –1: CIDR insertion and Day 0: 2 mg of oestradiol benzoate; Group BE48 (n = 40): Day –2: CIDR insertion and Day 0: 2 mg of oestradiol benzoate. All heifers were superstimulated on Day 3.5 (Day 0 = EB injection) with 290 NIH units of FSH (Folltropin, BionicheAnimal Health, Belleville, ON, Canada) in twice-daily decreasing doses over 4.5 days. On Day 6, all cows received 2 doses (a.m. and p.m.) of a prostaglandin F2α analogue (800 µg, Delprostenate, Glandinex, Universal Laboratory), and CIDR were removed on the morning of Day 7. Cows were injected with 10 µg of GnRH (Receptal, Intervet, Boxmeer, the Netherlands) on Day 8 a.m. and were inseminated 12 and 24 h later with semen of 3 bulls of proven fertility. On Day 15, ova/embryos were collected nonsurgically and evaluated in accordance with IETS guidelines. Data were analysed with a negative binomial regression model (Table 1). Administration of EB 24 or 48 h after CIDR insertion produced similar numbers of transferable and freezable embryos as well as total ova/embryos compared with addition of progesterone and EB at the moment of CIDR insertion. According to these results, EB could be administrated without progesterone injection either 24 or 48 h after CIDR insertion without compromising embryo production. Table 1.Embryo production of heifers superstimulated after additional progesterone (P4) and different times (24 or 48 h after CIDR insertion) of oestradiol benzoate administration (results are mean ± SE)


2016 ◽  
Vol 44 (05) ◽  
pp. 287-294 ◽  
Author(s):  
Ragab H. Mohamed ◽  
Mohamed Hossam ◽  
Axel Wehrend ◽  
Hassan A. Hussein

SummaryObjective: The aim of this study was to monitor the ovarian response and conception rate following estrous synchronization using CIDR, Ovsynch and double prostaglandin F2α protocols in Egyptian buffalo heifers. Material and methods: A total of 80 cyclic buffalo heifers were divided into four equal groups: CIDR (intravaginal progesterone releasing device, EAZI-BREEDTM CIDR®), Ovsynch (GnRH, PGF2α, GnRH injections), PGF (double PGF2α doses) and control. Timed artificial insemination (TAI) was performed in all heifers. All animals were exa - mined using ultrasound and blood samples were collected for measurement of progesterone. Results: A new follicular wave occurred earlier in the Ovsynch and PGF groups than in the CIDR group (p < 0.05). The mean diameter of the ovulatory follicle was smaller in the CIDR group than in the Ovsynch and PGF groups (p < 0.05). The ovulation rate was 100% in the CIDR group, 75% in the Ovsynch group and 70% in the PGF group. In the control group a lower pregnancy rate (20%) was determined in than in the CIDR (35%), Ovsynch (40%) and PGF (35%) groups. Progesterone concentrations were numerically higher in pregnant heifers of the CIDR group but the difference was non-significantly compared to the Ovsynch, PGF and control groups (p > 0.05). Conclusion and clinical relevance: EAZIBREEDTM CIDR®, Ovsynch-based TAI and PGF protocols were effective in synchronizing oestrus and resulted in nearly similar pregnancy rates in Egyptian buffalo heifers.


Sign in / Sign up

Export Citation Format

Share Document